Tag: inspection

Lessons Learned from a Critical IPC Skipped During Routine Manufacturing The pharmaceutical manufacturing process is intricate and tightly regulated, where a minor deviation can lead to significant consequences. This case…

Analysis of Unapproved Process Parameter Changes During Tech Transfer The pharmaceutical industry is governed by strict regulatory standards to ensure product safety and efficacy. However, deviations can occur, leading to…

Investigation of Skipped Critical IPC During Changeover: Insights from a Regulatory Impact Assessment In the world of pharmaceutical manufacturing, adherence to standardized operating procedures (SOPs) is paramount. This case study…

Investigation of a Deviation Closed without Effectiveness Check During Changeover In the pharmaceutical manufacturing sector, ensuring compliance with Good Manufacturing Practices (GMP) is paramount. An unresolved deviation during a critical…

Breakdown of FDA Inspection Observations Regarding Equipment Used Without Release During Changeover In the ever-vigilant arena of pharmaceutical manufacturing, regulatory compliance is paramount. A recent FDA inspection highlighted a significant…

Investigating Deviation Recurrence During Scale-Up: A Regulatory Perspective In pharmaceutical manufacturing, scale-up processes often expose underlying inefficiencies or failures. One crucial challenge that many manufacturers encounter is the recurrence of…

Regulatory Impact of Executing a Batch with Expired SOP: A Comprehensive Case Study In the dynamic field of pharmaceutical manufacturing, adherence to Standard Operating Procedures (SOPs) is paramount. However, the…

Regulatory Implications of Executing a Batch with an Expired SOP During Changeover: A Case Study In the pharmaceutical manufacturing sector, adherence to standard operating procedures (SOPs) is critical to ensuring…

Case Study: Executing a Batch with Expired SOP During Scale-Up and Its Impact on Compliance In the high-stakes environment of pharmaceutical manufacturing, adherence to Standard Operating Procedures (SOPs) is non-negotiable.…

Analyzing Deviation Recurrence in Batches During Changeover: Lessons from CAPA Failures In an increasingly regulated pharmaceutical environment, the occurrence of deviations during batch changeovers can significantly disrupt manufacturing operations. Such…

Case Study: Investigating Deviation Recurrence in a Commercial Campaign In pharmaceutical manufacturing, ensuring compliance with Good Manufacturing Practice (GMP) is crucial for maintaining product quality and safety. However, deviations can…

Breakdown of FDA Inspection Observations Related to Unapproved Process Parameter Changes During Tech Transfer In the pharmaceutical manufacturing environment, process integrity is essential to ensure compliance with Good Manufacturing Practices…